Vizgen is a biotechnology startup that operates in the field of spatial genomics. The company's flagship product is MERSCOPE, a high-resolution imaging platform that integrates single-cell and spatial multiomics analyses. This technology allows researchers to study biological samples at a cellular and subcellular level, providing a detailed understanding of the spatial organization of tissues and cells.

The company's technology is based on MERFISH chemistry, a method that enables high-quality, high-sensitivity spatial data collection. This technology is particularly useful in the field of immuno-oncology, where it can help researchers understand tumor and immune behavior across different types of human cancers.

Vizgen also offers a Gene Panel Design Portal, a user-friendly web-based application that guides researchers in building custom gene panels to run on the MERSCOPE platform. Additionally, the company provides a tool called VPT for cell segmentation, which draws cell boundaries and generates single-cell output by combining the results with MERFISH data.

Vizgen's business model revolves around selling its MERSCOPE platform and related services to research institutions and laboratories. The company generates revenue through the sale of its hardware platform, as well as through the provision of related services such as custom gene panel design and cell segmentation tools.

Keywords: Biotechnology, Spatial Genomics, MERSCOPE, Single-Cell Analysis, Multiomics Analysis, MERFISH Chemistry, Immuno-Oncology, Gene Panel Design, Cell Segmentation, Research Services.